Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura Dominici, M.D.

Concepts (194)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms582024208242.630 Why?
Mastectomy26202317932.560 Why?
Axilla1020235971.100 Why?
Mastectomy, Segmental1020249560.950 Why?
Sentinel Lymph Node Biopsy1220237100.910 Why?
Mammaplasty8202112040.750 Why?
Mastectomy, Modified Radical42023620.720 Why?
Lymph Nodes6202234760.690 Why?
Lymph Node Excision10202312620.650 Why?
Breast7202419700.600 Why?
Lymphedema120235340.570 Why?
Neoadjuvant Therapy10202327270.560 Why?
Nipples320202190.540 Why?
Paget's Disease, Mammary22013190.530 Why?
Pregnancy Complications, Neoplastic320162550.520 Why?
Genes, erbB-2220191620.520 Why?
Lymphatic Metastasis7202129240.490 Why?
Quality of Life72021128020.450 Why?
Neoplasm Staging142022110310.450 Why?
Carcinoma2202123750.420 Why?
Arm320245890.410 Why?
Breast Diseases220134430.370 Why?
Carcinoma, Ductal, Breast4201911000.360 Why?
Decision Support Techniques2202119560.360 Why?
Hyperplasia1201211850.340 Why?
Carcinoma, Lobular320194840.320 Why?
Antineoplastic Combined Chemotherapy Protocols82023115250.320 Why?
Neoplasm, Residual420229730.310 Why?
Female6020243801930.300 Why?
Neoplasm Recurrence, Local8202492400.300 Why?
Reoperation1201742010.300 Why?
Pain, Postoperative6202216430.300 Why?
Inflammatory Breast Neoplasms220191430.280 Why?
Radiotherapy, Adjuvant4202117710.270 Why?
Chemotherapy, Adjuvant6202234800.250 Why?
Humans6520247443660.220 Why?
Postoperative Complications62020152970.200 Why?
Breast Neoplasms, Male220212100.190 Why?
Decision Making4202238880.190 Why?
Carcinoma, Intraductal, Noninfiltrating220229480.190 Why?
Patient Satisfaction3202133950.170 Why?
Breast Implants220203870.170 Why?
Combined Modality Therapy5201986420.150 Why?
Adult2620222140520.150 Why?
Aged2020231632880.140 Why?
Carcinoma in Situ120228060.140 Why?
Prospective Studies132023532900.140 Why?
Neoplasm Invasiveness5201936160.140 Why?
Anesthesia, Conduction120192380.140 Why?
Retrospective Studies162023774600.140 Why?
Certification120194230.130 Why?
Receptors, Estrogen4202121900.130 Why?
Catastrophization120193160.130 Why?
Radiotherapy, Intensity-Modulated120218060.130 Why?
Prognosis112019290600.120 Why?
Receptor, erbB-24202324170.120 Why?
Young Adult102021564290.120 Why?
Genes, BRCA2120176180.120 Why?
Education, Medical, Continuing120198400.120 Why?
Patient Care120196400.110 Why?
Genes, BRCA1120177810.110 Why?
Antibodies, Monoclonal1201092740.110 Why?
Patient Participation1202214570.110 Why?
Middle Aged1820202133900.110 Why?
Neoplastic Cells, Circulating120199340.110 Why?
Age Factors52021183730.100 Why?
Hodgkin Disease1202014150.100 Why?
Receptors, Progesterone2201710980.100 Why?
Antineoplastic Agents22013136930.100 Why?
Aged, 80 and over102021577760.100 Why?
Cross-Sectional Studies22023250390.100 Why?
Mammography2201324750.100 Why?
Radiotherapy1201815330.100 Why?
Health Status Disparities1202217960.090 Why?
Psychometrics1202030030.090 Why?
Qualitative Research1201926820.090 Why?
Practice Guidelines as Topic2201872820.090 Why?
Ethics, Medical120157920.090 Why?
Intraoperative Care120137670.090 Why?
Treatment Outcome92021631070.080 Why?
Follow-Up Studies92019390520.080 Why?
Patient Education as Topic1201922780.080 Why?
Cyclophosphamide2201722420.080 Why?
Survival Rate42019127880.080 Why?
Thyroid Neoplasms1202222820.080 Why?
Radiographic Image Enhancement120138850.080 Why?
Sample Size120118450.080 Why?
Cellulitis120102060.080 Why?
Guideline Adherence1201822650.080 Why?
Socioeconomic Factors1202177850.080 Why?
Consensus1201629600.080 Why?
Healthcare Disparities1202231540.070 Why?
Abscess120106070.070 Why?
Venous Thromboembolism1201816710.070 Why?
Disease-Free Survival2202168960.070 Why?
Electronic Health Records1202244680.070 Why?
Body Image220206100.060 Why?
Fluorouracil1201016190.060 Why?
Hematoma120107580.060 Why?
Chi-Square Distribution1201135080.060 Why?
Health Knowledge, Attitudes, Practice1201939220.060 Why?
Massachusetts2202186620.060 Why?
Risk Assessment22018233360.060 Why?
Clinical Trials as Topic1201979140.060 Why?
Clinical Competence1201946870.060 Why?
Models, Statistical1201851010.060 Why?
Angiogenesis Inhibitors1201320380.060 Why?
Postpartum Period1201010860.060 Why?
Doxorubicin1201022340.060 Why?
Health Services Accessibility1201951350.050 Why?
Time Factors32017400750.050 Why?
Proportional Hazards Models22017123560.050 Why?
Pain Measurement3201934200.050 Why?
Ketoprofen1200080.050 Why?
Sudden Infant Death120032910.050 Why?
Kaplan-Meier Estimate1201165390.050 Why?
Analgesia, Patient-Controlled120001090.040 Why?
Randomized Controlled Trials as Topic1201699550.040 Why?
Biopsy1201167550.040 Why?
Serotonin1200310170.040 Why?
Surgical Instruments120223950.040 Why?
Physicians2201545670.040 Why?
Mind-Body Therapies120212470.040 Why?
Brain Stem120038460.040 Why?
Ambulatory Surgical Procedures120234550.040 Why?
Iodine Radioisotopes1202210320.040 Why?
Pregnancy42016291440.040 Why?
Anxiety2202242930.040 Why?
Preoperative Period120185500.040 Why?
Diagnosis, Differential12011129610.030 Why?
Morphine120006570.030 Why?
Benchmarking1202210420.030 Why?
Disease Management2201824600.030 Why?
Paclitaxel1202317080.030 Why?
Morbidity1202117680.030 Why?
Case-Control Studies22011217480.030 Why?
Health Plan Implementation120183520.030 Why?
United States42023698720.030 Why?
Anthracyclines120172880.030 Why?
Postmenopause1202424600.030 Why?
Registries2202280910.030 Why?
Exercise2202156150.030 Why?
Methylene Blue120141550.030 Why?
Taxoids120176660.030 Why?
Analgesics, Opioid2201836770.030 Why?
Hormones120178890.030 Why?
Data Collection1202233390.030 Why?
Republic of Korea120155380.030 Why?
Continuity of Patient Care1201910490.030 Why?
Exercise Therapy120199040.030 Why?
Depression2202277590.030 Why?
Coloring Agents120145660.020 Why?
Dermis120132070.020 Why?
Algorithms12011138820.020 Why?
Neoplasms12019216960.020 Why?
Anti-Inflammatory Agents, Non-Steroidal1200022820.020 Why?
Orthopedic Procedures1200012890.020 Why?
Preoperative Care1201922510.020 Why?
Demography1201516550.020 Why?
Risk Factors22018722960.020 Why?
Ultrasonography1202259840.020 Why?
Patient Selection1202142160.020 Why?
Patient Readmission1202331160.020 Why?
Efficiency, Organizational120136950.020 Why?
Gestational Age1201634930.020 Why?
Stress, Psychological1202242450.020 Why?
Pilot Projects1201983190.020 Why?
Hemorrhage1201834610.020 Why?
Longitudinal Studies12022139910.020 Why?
Cohort Studies22020405590.020 Why?
Infant, Newborn22022256280.020 Why?
Medicare1202365660.020 Why?
Lysergic Acid Diethylamide12003480.010 Why?
Infant22022351340.010 Why?
Hospitalization12023102590.010 Why?
Cell Proliferation12019104830.010 Why?
Receptors, Serotonin120032010.010 Why?
Autoradiography120037450.010 Why?
Adolescent32019857790.010 Why?
Smoke120032270.010 Why?
Reproducibility of Results12020199050.010 Why?
Severity of Illness Index12019155350.010 Why?
Physician-Patient Relations1201332290.010 Why?
Indians, North American120033550.010 Why?
Attitude of Health Personnel1201338410.010 Why?
Skin1201343720.010 Why?
Ethanol1200313420.010 Why?
Interviews as Topic1200325390.010 Why?
Placebos1200016760.010 Why?
Drug Combinations1200019580.010 Why?
Binding Sites1200361110.010 Why?
Male320213501150.010 Why?
Prenatal Exposure Delayed Effects1200324080.010 Why?
Double-Blind Method12000120250.000 Why?
Dominici's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (194)
Explore
_
Co-Authors (74)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.